Results of adjuvant treatments in breast cancer patients over 70 years old: the IBCSG experience. International Breast Cancer Study Group
Crivellari, D.
Tumori 88(1 Suppl. 1): S81-S82
2002
ISSN/ISBN: 0300-8916 PMID: 11989935 Document Number: 544608
Document emailed within 1 workday
Related Documents
Castiglione-Gertsch, M.; Tattersall, M.; Hacking, A.; Goldhirsch, A.; Gudgeon, A.; Gelber, R.D.; Lindtner, J.; Coates, A.; Collins, J.; Isley, M.; Senn, H.J.; Rudenstam, C.M. 1997: Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group European Journal of Cancer 33(14): 2321-23252006: Comparative effects of the administration period of adjuvant chemotherapy using doxifluridine (5'-DFUR) for 1 year versus 3 years after breast cancer surgery by the Shimane Breast Cancer Study Group Anticancer Research 26(1b): 591-597
Tominaga, T.; Abe, O.; Izuo, M.; Isono, K.; Enomoto, K.; Nishi, M.; Fukami, A.; Muto, T.; Morioka, Y.; Watanabe, H. 1993: Correlations between estrogen receptor and prognostic factors of patients with breast cancer. the Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2171-2176
Mitsuyama, S.; Kuroda, Y.; Ohsato, K.; Nakamura, Y.; Murakami, F.; Nishikata, F.; Ikeda, S.; Egami, T.; Mori, A.; Ohe, H. 1996: Administration method and recurrence-preventing effect of medroxyprogesterone acetate (MPA) as a postoperative adjuvant endocrine therapy for stage III breast cancer. Kitakyushu Collaborative Study Group for Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(9): 1153-1160
Fortunato, L.; Drago, S.; Vitelli, C.E.; Santoni, M.; Gucciardo, G.; Cabassi, A.; Farina, M.; La Pinta, M.; Remedi, M.; Pagano, G.; Silipod, T.; Terribile, D.; Stagnitto, D.; Grassi, G.B. 2006: Sentinel lymph node biopsy in breast cancer. Experience of the Rome Breast Cancer Study Group Chirurgia Italiana 58(6): 689-696
Yoshida, M.; Saji, S.; Takagi, H.; Takeuchi, S.; Tsuda, H.; Nimura, Y.; Mizumoto, R.; Miyazaki, I.; Kobayashi, S.; Noguchi, M. 1993: A comparative study among ftorafur, ftorafur plus tamoxifen, and tamoxifen in adjuvant therapy for breast cancer. the Chubu Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(15): 2325-2333
Semiglazov, V.F.; Moiseenko, V.M.; Bavli, I.L.; Migmanova, N.Sh.; Seleznev, I.K. 1988: Work experience of the WHO International Reference Center in assessing the effectiveness of self-examination for the early diagnosis of breast cancer (results of 2 years' research) Voprosy Onkologii 34(8): 969-974
Taguchi, T.; Koyama, H.; Yayoi, K.; Wada, T.; Takatsuka, Y.; Sonoo, H.; Morimoto, K.; Tominaga, T.; Abe, R.; Enomoto, K. 1995: Long-term clinical study on TAP-144-SR, an LH-RH agonist depot formulation, in premenopausal patients with advanced or recurrent breast cancer. TAP-144-SR Breast Cancer Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(4): 495-508
1990: Prognostic importance of occult axillary lymph node micrometastases from breast cancers. International (Ludwig) Breast Cancer Study Group Lancet 335(8705): 1565-1568
Nabholtz, J.M.; Lindsay, M.A.; Hugh, J.; Mackey, J.; Smylie, M.; Au, H.J.; Tonkin, K.; Allen, M. 1999: The academic global virtual concept in clinical cancer research and its application to breast cancer: The Breast Cancer International Research Group Seminars in Oncology 26(3 Suppl. 8): 4-8
Salvadori, B.; Celio, L.; Oriana, R.; Bajetta, E. 2000: Adjuvant oophorectomy versus CMF in premenopausal node-positive breast cancer: long-term results of an experience at the Milan Cancer Institute Tumori 86(3): 258-259
2004: Adjuvant chemotherapy for early breast cancer: protocol and nonprotocol treatment options. Proceedings of a national research leader think tank and 3 regional breast cancer update working group meetings. July-October 2003 Oncology 18(4 Suppl. 1): 5-22
Lindahl, B.; Andolf, E.; Ingvar, C.; Ranstam, J.; Willén, R. 2008: Adjuvant tamoxifen in breast cancer patients affects the endometrium by time, an effect remaining years after end of treatment and results in an increased frequency of endometrial carcinoma Anticancer Research 28(2b): 1259-1262
Rookus, M.A.; van Leeuwen, F.E. 1994: Oral contraceptives and risk of breast cancer in women aged 20-54 years. Netherlands Oral Contraceptives and Breast Cancer Study Group Lancet 344(8926): 844-851
Rookus, M.A.; van Leeuwen, F.E. 1994: Oral contraceptives and risk of breast cancer in women aged 20-54 years. Netherlands Oral Contraceptives and Breast Cancer Study Group Lancet 344(8926): 844-851
Balducci, L.; Extermann, M.; Fentiman, I.; Monfardini, S.; Perrone, F. 1997: Should adjuvant chemotherapy be used to treat breast cancer in elderly patients (> or = 70 years of age)? European Journal of Cancer 33(11): 1720-1724
Perrone, F.; De Maio, E. 2002: Should adjuvant chemotherapy be used to treat breast cancer in elderly patients (> or = 70 years of age)? Pro Tumori 88(1 Suppl. 1): S89-S90
Ansquer, Y.; Gautier, C.; Fourquet, A.; Asselain, B.; Stoppa-Lyonnet, D. 1998: Survival in early-onset BRCA1 breast-cancer patients. Institut Curie Breast Cancer Group Lancet 352(9127): 541
Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712
Rosenberg, L.; Palmer, J.R.; Shapiro, S. 1992: Oestrogen replacement therapy and breast cancer Results from the Slone Epidemiology Units Toronto Breast Cancer Study Mann, R D Hormone replacement therapy and breast cancer risk : 253-264